Cyclophosphamide-induced ovarian failure.
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001706:Biopsy; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004967:Estrogens / Q000652:urine; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy; D006062:Gonadotropins / Q000652:urine; D006801:Humans; D010049:Ovarian Diseases / Q000139:chemically induced* / Q000473:pathology; D010053:Ovary / Q000187:drug effects / Q000473:pathology; D010063:Ovum; D013997:Time Factors
D004967:Estrogens; D006062:Gonadotropins; D003520:Cyclophosphamide; D003404:Creatinine